BDX (bd.com) Company Net Assets

Brandmark of bd.com (BDX)

This Becton Dickinson & Co (BDX) price chart illustrates the price action of the medical equipment manufacturer, whose value is currently 24.34. Becton Dickinson & Co is scaling its portfolio of intelligent drug delivery systems and laboratory analysis. Growth is driven by mergers and digital partnerships within the IT sector. Meanwhile, the business is countering pressure from tech startups and corporate behemoths in the competition for hospital contracts.

BDX bd.com Book Capitalization (07/04/2022 - 10/28/2026)

Financial and market metric breakdowns for Becton Dickinson (BDX)

- price and consensus price forecast:
Share Price Becton Dickinson & Company|BDX - Price Target Chart
- market capitalization data:
Market Valuation Becton, Dickinson and Company|BDX - Enterprise Value
- book capitalization data:
Net Asset Value per Share Becton Dickinson|BDX - Book Capitalization|Capitalization to Book Value Ratio bd.com|BDX - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Becton Dickinson & Co|BDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio BD|BDX - Company Aggregate Debts|Debts to Book Capitalization Becton, Dickinson and Company
Fundamental company valuation:Becton Dickinson & Company - BDX
Mass-produced product of Becton, Dickinson and Company

Becton Dickinson & Co (BDX) maintains its leadership in the medical consumables sector through systemic innovation. This indicator reflects the difference between total assets and liabilities, excluding market volatility. By analyzing the movement of the company's balance sheet capital, an investor assesses the real value of net assets. Effective M&A management by top executives directly impacts the growth of this fundamental base. A stable trend confirms the long-term resilience of the business.

Competitor analysis

ISRG: Accounting Capitalization|DHR (Danaher Corp.) - Company Book Value|steris.com (STE) - Company Net Assets|Book Capitalization WST (West Pharmaceutical Services, Inc.)|Total Stockholders' Equity Baxter International Inc.|Book Capitalization Masimo Personal Health MASI|Accounting Capitalization Stevanato Group Corp (STVN)|Book Capitalization TFX|Book Valuation of Business merit.com MMSI|NVST: Book Capitalization|ICUI - Company Net Assets|XRAY: Book Capitalization|LMAT (LeMaitre Corp) - Book Capitalization|Company Book Value AtriCure, Inc.|Company Book Value staar.com (STAA)|ChromaDex Corporation (NAGE) - Company Net Assets|Accounting Value of Company ZimVie Inc (ZIMV)|Book Capitalization ANGO|Cerus Inc - Book Valuation of Business|Alpha Teknova, Inc. (TKNO) - Company Book Value|MGRM: Accounting Capitalization|sharpstechnology.com - Company Book Value|Book Valuation of Business InfuSystem Holdings, Inc.|Utah Medical (UTMD) - Company Net Assets|Total Net Assets KRMD|Nyxoah S.A. (NYXH) - Company Book Value|Accounting Value of Company microbotmedical.com MBOT|Company Net Assets PDEX (Pro-Dex)|Zentek Ltd - Book Capitalization|ELUT: Company Book Value|MLSS - Company Net Assets|Book Capitalization NXGL|RVP (Retractable Technologies, Inc.) - Total Stockholders' Equity|Company Book Value Harvard Bioscience, Inc. (HBIO)|Accounting Capitalization Femasys Inc (FEMY)|Company Net Assets MeihuaMed|Total Net Assets POAI (predictive-oncology.com)|Company Book Value CJMB|Book Valuation of Business atrioncorp.com ATRI|NURO - Book Capitalization